Phocas Financial Corp.
- SEC CIK
- 0001356783
- Latest filing
- Jul 30, 2026
AXSM holding history
Axsome Therapeutics, Inc. in every 13F filed by Phocas Financial Corp., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −16,588−100.0% | Sold out | Holders |
| Q1 2025 | 16,588 | $1.93M | 0.3% | −958−5.5% | Reduced | Holders |
| Q4 2024 | 17,546 | $1.49M | 0.2% | −155−0.9% | Reduced | Holders |
| Q3 2024 | 17,701 | $1.59M | 0.2% | −1,098−5.8% | Reduced | Holders |
| Q2 2024 | 18,799 | $1.51M | 0.2% | −355−1.9% | Reduced | Holders |
| Q1 2024 | 19,154 | $1.53M | 0.2% | −7,736−28.8% | Reduced | Holders |
| Q4 2023 | 26,890 | $2.14M | 0.3% | +26,890 | New | Holders |